摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(AgCl(PPh3)2) | 82474-94-0

中文名称
——
中文别名
——
英文名称
(AgCl(PPh3)2)
英文别名
[AgCl(PPh3)2];chlorosilver;triphenylphosphane
(AgCl(PPh3)2)化学式
CAS
82474-94-0
化学式
C36H30AgClP2
mdl
——
分子量
667.903
InChiKey
AVNLKIIWDFFLDC-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.58
  • 重原子数:
    40.0
  • 可旋转键数:
    8.0
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    0.0
  • 氢给体数:
    0.0
  • 氢受体数:
    0.0

SDS

SDS:6f9ee8f6ae470b9cf54f23dd0c2d2c11
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (AgCl(PPh3)2)sodium 作用下, 以 乙醚 为溶剂, 反应 74.0h, 生成 bis(triphenylphosphine)silver(I)gallium(III) tetraethylthiolate
    参考文献:
    名称:
    MES2黄铜矿材料的双金属单源前驱体(Ph3P)2M(µSEt)2E(SEt)2的合成与表征(M = Cu,Ag和E = In,Ga,Al)
    摘要:
    我们报告了I–III双金属配合物(Ph 3 P)2 M(µSEt)2 E(SEt)2(M = Cu,Ag和E = In,Ga,Al)的合成和表征,以及( Ph 3 P)2 M(µ-Cl)2氯化铝2合成过程中分离出的复合物。硫醇盐络合物可用作单源前体(SSP),以制备各种I–III硫族化物半导体材料。制备该系列的一些SSP需要反应条件的微小变化。通过X射线衍射对有机金属配合物进行结构表征。比较了SSP的固态结构,基本反应性和作为黄铜矿材料前体的潜在适用性。
    DOI:
    10.1002/ejic.201700115
  • 作为产物:
    描述:
    silver(I) chloride三苯基膦 作用下, 以 氯仿 为溶剂, 生成 (AgCl(PPh3)2)
    参考文献:
    名称:
    A reinvestigation of some triphenylphosphinesilver halide complexes and their reaction with stannous chloride: 119mSn Mössbauer and 31P FT NMR studies
    摘要:
    DOI:
    10.1016/s0020-1693(00)87331-4
点击查看最新优质反应信息

文献信息

  • Synthesis and characterization of ternary AgInS2 nanocrystals by dual- and multiple-source methods
    作者:Lu Tian、Jagadese J. Vittal
    DOI:10.1039/b707960e
    日期:——
    The precursors [In(bipy)(SCO}Ph)3] and [Ag(SCO}Ph)] have been used to prepare monodispersed polyhedral shaped AgInS2 nanocrystals (NCs). The NCs were fully characterized by X-ray powder diffraction, transmission electron microscopy, selected area electron diffraction and energy dispersive X-ray analysis. The synthesis of AgInS2 NCs was further investigated by varying the dual- and multiple-source precursors and other parameters such as surfactants, surfactant ratio, temperature and time duration, to optimize the conditions to get better quality NCs. In all these reactions, a heterobimetallic thiobenzoate intermediate similar to the single-source precursor [(Ph3P)2AgIn(SCO}Ph)4] has been proposed to have formed which decompose subsequently to AgInS2 NCs.
    利用前驱体[In(bipy)(SCO}Ph)3]和[Ag(SCO}Ph)]制备了单分散多面体形状的 AgInS2 纳米晶体(NCs)。通过 X 射线粉末衍射、透射电子显微镜、选区电子衍射和能量色散 X 射线分析对这些纳米晶体进行了全面表征。通过改变双源和多源前驱体以及表面活性剂、表面活性剂比例、温度和持续时间等其他参数,进一步研究了 AgInS2 NCs 的合成,以优化条件,获得更高质量的 NCs。在所有这些反应中,都形成了与单源前体[(Ph3P)2AgIn(SCO}Ph)4]类似的硫代苯甲酸异重属中间体,随后分解成 AgInS2 NCs。
  • Chemistry of the PC<sup>NHC</sup>P Ligand:  Silver and Ruthenium Complexes, Facial/Meridional Coordination, and Catalytic Transfer Hydrogenation
    作者:Pei Ling Chiu、Hon Man Lee
    DOI:10.1021/om049070v
    日期:2005.3.1
    Significantly, complex 3 can also be prepared directly from PCNHCP·HCl and RuCl2(PPh3)3 in the absence of base. Reactions of 3 with CO, phenylacetylene, and pyridine afford mer complexes mer,cis-RuCl2(CO)(PCNHCP) (4), mer,trans-RuCl2(CCHPh)(PCNHCP) (6), and mer,trans-[RuCl(py)2(PCNHCP)]Cl (7), respectively. The fac complex, fac,cis-[RuCl(bipy)(PCNHCP)]Cl (8), was produced in reaction of either 3 or
    PC NHC P的络合物被鉴定为[Ag 3(μ-Cl)(PC NHC P)2 ] Cl 2(1)。1与AgNO 3的阴离子交换得到白色化合物,该化合物结晶为两种形式,即[Ag 3(μ-Cl)(PC NHC P)] 2(NO 3)2(2a)和[Ag 3(Cl)(NO 3)(0.5DMF)(PC NHC P)2 ] NO 3(2b),来自不同的溶剂组合。它们的结构确定揭示了令人感兴趣的结构特征,包括两者中的短的Ag··Ag相互作用。不像的共制剂(II)NHC络合物在文献之间的新的卡宾转移反应1和的RuCl 2(PPH)3产生FAC - [孺2(μ-Cl)的3(PC NHC P)2 ](3),产量高。卡宾转移反应的非氧化还原性质与早期报道不同,表明通过卡宾转移制备二价NHC络合物是可行的合成途径。重要的是,在不存在碱的情况下,复合物3也可以直接由PC NHC P·HCl和RuCl 2(PPh
  • Crystal and Molecular Structure of Palladium(II) and Silver(I) Complexes with Oxotetrazolinate Ligands [1-Me-N4C(O)]<sup>-</sup>
    作者:Heinrich Noth、Klaus Burger、Wolfgang Beck
    DOI:10.1515/znb-2011-0917
    日期:2011.9.1
    The structures of (n-Bu3P)2Pd[1-Me-N4C(O)]2 (1) and of (Ph3P)3Ag[1-Me-N4C(O)] ・ 1-Me-4-H-N4C(O) (2) were determined by X-ray crystallography. The oxotetrazolinate ligands are N4-coordinated in contrast to the corresponding Scoordinated tetrazole-thionates. Graphical Abstract Crystal and Molecular Structure of Palladium(II) and Silver(I) Complexes with Oxotetrazolinate Ligands [1-Me-N4C(O)]-
    (n-Bu3P)2Pd[1-Me-N4C(O)]2 (1) 和 (Ph3P)3Ag[1-Me-N4C(O)] · 1-Me-4-H-N4C( O) (2) 由 X 射线晶体学测定。与相应的配位四唑-亚硫酸盐相比,氧代四唑配体是 N4 配位的。 (II) 和 (I) 配合物与氧代四唑配体的图形抽象晶体和分子结构 [1-Me-N4C(O)]-
  • Synthesis and structure of [(Ph3P)2Ag(μ-Cl)(μ-SC{O}Ph)In(SC{O}Ph)2]
    作者:Theivanayagam C. Deivaraj、Jagadese J. Vittal
    DOI:10.1016/s0020-1693(02)00908-8
    日期:2002.7
    The synthesis and structure of the hetero-bimetallic compound [(Ph3P)(2)Ag(mu-Cl)(mu-SCO}Ph-S)In(SCO}Ph)(2)] have been reported. The compound was synthesized by reacting [(Ph3P)(2)AgCl], InCl3.4H(2)O and NaSCO}Ph in the ratio 1:1:3 in a mixture of solvents. The structure of the compound has been determined by X-ray crystallography, The compound contains a nonplanar AgClSIn core. (C) 2002 Elsevier Science B.V. All rights reserved.
  • A Pentanuclear Mixed Gold(III)−Silver(I) Phosphide with an Unusual T-Frame μ<sub>3</sub>-Cl Bridge
    作者:M. Carmen Blanco、Eduardo J. Fernández、M. Elena Olmos、Olga Crespo、Antonio Laguna、Peter G. Jones
    DOI:10.1021/om020142x
    日期:2002.6.1
    The reaction of the mixed gold(III)-silver(I) diphenylphosphide complex [Au(C6F5)(2)(mu-PPh2)(2)Ag](2) (1) with an equimolecular amount of [AgCl(PPh3)(2)] leads to the formal insertion of the latter into 1, affording the pentanuclear derivative [Au(C6F5)(2)(mu-PPh2)AgPPh3}(mu-PPh2)}(2)(mu-Ag)(mu(3)-Cl)] (2). Surprisingly, complex 2 is also obtained by treatment of [Au(C6F5)(2)(PPh2H)(2)]ClO4 with [Ag(TfO)(PPh3)] (TfO = trifluoromethanesulfonate) and AgTfO (2:2:1) in the presence of PPN(acac) (PPN = [N(PPh3)(2)](+), acac = acetylacetonate) and PPNCl. The crystal structure of 2 has been determined by X-ray diffraction studies, and it displays an unusual, perfectly planar T-frame mu(3)-Cl atom acting as a bridge between the three silver atoms.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫